| Clinical data | |
|---|---|
| Other names | Clomagestone acetate; SH-741; 6-Chloro-17α-acetoxy-16α-methylpregna-4,6-diene-3,20-dione |
| Drug class | Progestogen;Progestogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C24H31ClO4 |
| Molar mass | 418.96 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Clomegestone acetate (USANTooltip United States Adopted Name) (developmental code nameSH-741), orclomagestone acetate, also known as6-chloro-17α-acetoxy-16α-methylpregna-4,6-diene-3,20-dione, is asteroidalprogestin of the17α-hydroxyprogesterone group which was developed as anoral contraceptive but was never marketed.[1][2] It is theacetateester ofclomegestone, which, similarly to clomegestone acetate, was never marketed.[1] Clomegestone acetate is also the 17-desoxycogener ofclometherone, and is somewhat more potent in comparison.[3] Similarly tocyproterone acetate, clomegestone acetate has been found to alterinsulin receptor concentrations inadipose tissue,[4] and this may indicate the presence ofglucocorticoid activity.[5][6]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |